REG - Frontier IP Group - Strategic partnership for Cambridge innovation hub

Frontier IPAnnouncement

13/06/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250613:nRSM6819Ma&default-theme=true

RNS Number : 6819M  Frontier IP Group plc  13 June 2025

RNS

AIM: FIPP

13 June 2025

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Strategic partnership to develop innovation hub in Cambridge to accelerate
scale up and growth

 

Frontier IP, a specialist in commercialising intellectual property, today
announces it has entered into a strategic partnership with Abstract Mid-Tech
Limited ("Abstract"), an associate company of Abstract Securities Limited, a
specialist in commercial property development, investment and venture capital
financing, to create a new innovation hub in Cambridge.

 

The partnership will see the Group take a 20-year lease on a facility
dedicated to start up and early- stage science and technology companies at
Abstract's newly developed South Cambridge Science Centre ("SCSC" or the
"Centre") in Sawston, Cambridge.

 

Frontier IP intends to sublet space to its portfolio companies and other
innovative companies aligned with the Group's focus on deep technology and
life sciences. The Group will also move its commercialisation team, currently
based in Duxford, Cambridge, into the facility. In return for becoming an
anchor tenant, Abstract has paid Frontier IP an upfront cash payment of £1
million and will provide the space rent free for the first 12 months of
Frontier IP's occupancy.

 

Developing a facility at the SCSC will enable Frontier IP to cement and
strengthen its presence at the heart of a world-leading Cambridge science and
technology ecosystem and, by extension, within the UK's innovation golden
triangle of Cambridge, Oxford and London.

 

The SCSC is strategically located close to the Cambridge Biomedical Campus,
which includes Addenbrookes Hospital, GSK, AstraZeneca, the Babraham Research
Campus, Granta Park and Unity Campus. It is close to road and rail links and
the city centre. This means it is easy to reach for our networks of industry
partners, investors and capital providers in Cambridge and those from further
afield in the UK and internationally. The Centre will also provide a base to
support Frontier IP's other portfolio companies from elsewhere in the UK,
Italy and Portugal.

 

The Group believes the innovation hub has the potential to launch a step
change in the Group's scale up and growth since a central, physical location
will have the potential to:

 

·    Make it easier to identify and access new deal flow. As well as
raising Frontier IP's profile in the Cambridge ecosystem, the space will offer
prospective companies high-quality space and networking opportunities and
regular interaction with Frontier IP;

·    Accelerate development and growth of new and existing portfolio
companies and improve operational efficiency. The Group provides hands-on
commercialisation services to start-up and early-stage companies. Direct
contact between Frontier IP's commercialisation team and portfolio companies
day-to-day should help to reduce costs and drive projects forward at pace;

·    Improve access to funding for the Group and the portfolio. The Centre
will enable Frontier IP to showcase companies from across the portfolio to
leverage relationships with existing investors and attract new investors; and

 

·    Accelerate exits and realisations. A central location for Frontier IP
and its portfolio companies to support marketing and promotion to corporate
partners, funders and acquirers. The Group intends to use the facility as a
base for regular events.

Under the terms of the agreement, Frontier IP is taking one floor of 18,000
square feet in the SCSC. The Group will be responsible for the costs
associated with the innovation hub, including investment in expanding or
improving facilities, but will profit from any rental income above a
conservatively modelled breakeven point.

 

Cambridge is one of the world's leading centres for innovation and is a magnet
for scientists, engineers and technologists. There is strong demand for space
in the city and its environs. Frontier IP believes its offering to prospective
tenants will be competitive.

 

It is anticipated that the Frontier IP innovation hub will open by the end of
2025.

 

Frontier IP Chief Executive Officer Neil Crabb said: "I am excited by the
possibilities offered when our innovation hub opens. I believe it will provide
the basis to transform Frontier IP's growth potential. We anticipate that a
number of our portfolio companies will move in and that it will prove highly
attractive to other potential start-ups and early-stage companies because of
its place at the centre of Cambridge's investor and science and technology
networks.

 

"Our business model is based on identifying promising IP and providing
hands-on commercialisation services to build successful businesses. Having a
much closer physical presence between our commercialisation teams, portfolio
companies and potential portfolio companies will enable us to accelerate their
development and scale-up, and, eventually, successful exits."

 

Abstract Chief Executive Officer, Mark Glatman, said: "We are delighted to
welcome Frontier IP as our first occupier at the SCSC so soon after completing
the first phase of development.  This commitment is one of the most
significant lettings in the wider Cambridge science market during 2025. It
provides a very complementary offering within the space we have developed,
creating synergies for a range of potential future occupiers from startups to
more established life science and technology companies. They stand to benefit
from close proximity to Frontier IP, investors, their portfolio companies and
some of the specialist technology they will have in their facilities."

 

 

ENQUIRIES

 

 Frontier IP Group Plc                                                  T: 020 7332 2338
 Neil Crabb, Chief Executive                                            neil@frontierip.co.uk

 Andrew Johnson, Communications & Investor Relations                    M: 07464 546 025

 Company website: www.frontierip.co.uk (http://www.frontierip.co.uk/)
 Abstract Securities Limited

 Mark Glatman                                                           T: 07765 231 555

 mark.glatman@abstractsecurities.com

 Allenby Capital Limited (Nominated Adviser)                            T: 0203 328 5656

 Nick Athanas / Daniel Dearden-Williams

 Singer Capital Markets (Broker)                                        T: 0207 496 3000

 Charles Leigh-Pemberton / James Fischer

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGZGMVGZRGKZZ